Cheng Liu
13Patents
6h-index
13Co-inventors
63Inventor score
Filing activity: Feb 7, 1991 → Feb 20, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5261410A | Method for determining if a tissue is a malignant tumor tissue, a benign tumor tissue, or a normal or benign tissue using Raman spectroscopy | Physics | 283 | Expired |
| US5293872A | Method for distinguishing between calcified atherosclerotic tissue and fibrous atherosclerotic tissue or normal cardiovascular tissue using Raman spectroscopy | Physics | 263 | Expired |
| US5635402A | Technique for determining whether a cell is malignant as opposed to non-malignant using extrinsic fluorescence spectroscopy | Physics | 69 | Expired |
| US6346101B1 | Photon-mediated introduction of biological materials into cells and/or cellular components | Chemistry; Metallurgy | 59 | Expired |
| US5656810A | Method and apparatus for evaluating the composition of an oil sample | Physics | 37 | Expired |
| US7608591B2 | Targeted delivery to legumain-expressing cells | Physics | 18 | Active |
| US10426349B2 | Resonance Raman spectroscopy analyzer instrument for biomolecules in tissues and cells | Human Necessities | 1 | Active |
| US11319341B2 | Immune-stimulating soluble doxorubicin-conjugated complex | Chemistry; Metallurgy | 0 | Active |
| US9982011B2 | Legumain activated doxorubicin derivative as well as preparation method and application thereof | Chemistry; Metallurgy | 0 | Active |
| US9161959B2 | Use of a vegetable drug composition in the manufacturing of pharmaceutical preparation for the treatment of portal hypertension caused by hepatocirrhosis | Human Necessities | 0 | Active |
| US10744207B2 | Biological complexes and methods for using same | Chemistry; Metallurgy | 0 | Active |
| US11078232B2 | Preparation and use of molecular site targeted and activated kinase inhibitor | Human Necessities | 0 | Active |
| US7399743B2 | Targeted thrombosis | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.